|
|
| Line 35: |
Line 35: |
|
| |
|
|
| |
|
| [[Image:Osm interact osmr.png|frame|left|'''Fig.2''' Complementarity between the interaction surfaces of hOSM and gp130.The solvent-accessible surfaces of site 2 on hOSM (left) and the cognate binding site on gp130 (right) are displayed with areas contributed by residues implicated in binding highlighted as coloured patches.]] [[Image:Oncostatin site3.jpg|frame|center|'''Fig.3''' Site 3 configuration with residues for OSMR and LIFR binding in red.]]
| | |
| | | |
|
| |
|
| Line 46: |
Line 46: |
|
| |
|
|
| |
|
| [[Image:Onco mécha.jpg|center|frame|'''Fig.4''' The different pathways in which oncostatin M is involved.]] | | [[Image:Onco mécha.jpg|center|frame|'''Fig.2''' The different pathways in which oncostatin M is involved.]] |
|
| |
|
|
| |
|